Boundless Bio, Inc.BOLDNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR+10.5%
5Y CAGR-14.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+10.5%/yr
vs -6.2%/yr prior
5Y CAGR
-14.2%/yr
Recent acceleration
Acceleration
+16.7pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $62.62M | -13.2% |
| 2024 | $72.18M | +31.7% |
| 2023 | $54.80M | +17.9% |
| 2022 | $46.47M | +83.7% |
| 2021 | $25.30M | -81.2% |
| 2018 | $134.37M | +44.2% |
| 2017 | $93.18M | +55.2% |
| 2016 | $60.05M | - |